Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00146588
Status:
COMPLETED
Last Update Posted:
2015-03-24
First Post:
2005-09-06
Brief Title:
Cytoxan Epirubicin and Capecitabine in Women With Breast Cancer
Sponsor:
Craig A Bunnell MD MPH
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
02-036
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Craig A Bunnell MD MPH
Lead Sponsor Class:
OTHER
Responsible Party:
Craig A Bunnell MD MPH
Responsible Party Title:
Associate Chief Medical Officer
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pharmacia | INDUSTRY |
| Dana-Farber Cancer Institute | OTHER |
| Massachusetts General Hospital | OTHER |
| Brigham and Womens Hospital | OTHER |
| Beth Israel Deaconess Medical Center | OTHER |